Sandy joined our Group in 2012.
Sandy started as a customer service executive in OESC in 2012. She was then re-designated as a human resources executive in 2013, where she was exposed to various type of works relating to human resources management of our Group. She was promoted to Marketing Director one year later and took charge of sales and marketing activities of the Group. Subsequently, she was appointed as our Chief Executive Officer in 2017.
Upon joining the Group, Sandy has been responsible for developing and implementing marketing strategies to elevate our Group’s branding with the aim of increasing market share in the eye specialist industry. She is also responsible for developing new business opportunities, particularly in promoting our Group’s business and services in the eye specialist industry. It is anticipated that going forward, she will continue to play a similar role within the Group.
Sandy holds 2,060,000 ordinary shares and 515,000 warrants directly in the Company.
Dr. Stephen Chung (“Dr. Stephen”), joined our Group in 1995.
Dr. Stephen first joined OESC as a consultant ophthalmologist. He underwent training with eye surgeons from Optimax UK for the understanding of thenrevolutionary Photorefractive Keratectomy (PRK) refractive laser procedure. He later went on to perform the first PRK operation in OESC.
After fully dedicating his time to OESC, he took the initiative to enhance his skills by adapting and mastering the latest innovations and evolutions of laser technology in the field of ophthalmology by carrying out the femtosecond assisted laser in-situ (FemtoLASIK) procedure in 2005, and the Small Incision Lenticule Extraction (SMILE®) procedure in 2013, and expanding the specialist services that our Group could offer to existing and potential customers.
Dr. Stephen is our Senior Medical Director and substantial shareholder with over 36 years of experience in the eye care industry. He is mainly stationed at our eye specialist centre located at Taman Tun Dr. Ismail, Kuala Lumpur and further provides his services at our eye specialist centres in Kuching and Ipoh on an ad-hoc basis by performing refractive surgeries. Dr. Stephen is also primarily responsible for providing refractive surgeries training to our doctors. He is also the Chairman of our Group’s Medical Committee, which is primarily responsible for introducing rules and standard operating procedures to be adopted by our specialist hospital, ambulatory care centres, and clinics and applied by our doctors.
Dr. Stephen holds 30,720,000 ordinary shares and 7,430,000 warrants directly in the Company.
Dr. Chuah Kay Leong (“Dr. Chuah”) joined our Group in 2002.
Dr. Chuah first joined OESC as a Consultant Ophthalmologist, bringing with him over 10 years of experience in the eye care industry. He has since been working closely with our Group and is primarily responsible for providing technical and clinical leadership support and mentorship to the cataract surgeons and ophthalmic nurses.
He sits on our Group’s Medical Committee and his primary responsibility is to introduce the rules and standard operating procedures that are applied by all our doctors and adopted by our specialist hospital, ambulatory care centres and clinics.
Dr. Chuah holds 20,170,000 ordinary shares and 3,742,500 warrants directly in the Company.
Dr. Lam Hee Hong (“Dr. Lam”) joined our Group in January 2018.
A veteran in the eye care industry, Dr. Lam first affiliated with OESC when his clinic, Lam Eye Specialist business and assets were acquired by OESC in 2016. He officially joined our Group as an Ophthalmologist in January 2018 and upon joining the Group, he has since contributed substantially to the expansion of our Group into the Southern region by taking part in the implementation of marketing strategies to strengthen the presence of our Group there.
He was also involved in the process of setting up our branches in Segamat and Kluang. Dr. Lam is responsible for monitoring the performance of the specialist doctors within our Group by coordinating and obtaining feedback from customers and then relaying the responses and assessments to our doctors.
He sits on our Group’s Medical Committee, which is primarily responsible for introducing rules and standard operating procedures to be adopted by our specialist hospital, ambulatory care centres and clinics and to be applied by our doctors.
Dr. Lam does not hold any ordinary shares and warrants in the Company.
Pang Woei Yaw (“Pang”) joined our Group in September 2018.
Pang was a corporate finance manager for Sena Diecasting Industries Sdn Bhd, where he was primarily responsible for the financing and accounting matters of the company, including preparing monthly management accounts and financial reports and identifying areas for improvement in finance operations. During his employment with Sena Diecasting Industries Sdn Bhd, he was seconded to OESC and placed in charge of reviewing the financial statements of our Group and providing related financing advisory services.
He left Sena Diecasting Industries Sdn Bhd and joined OESC as the Group Accountant. He is responsible for accounting and tax-related matters of our Group, including reviewing the financial statements and audit reports of our Group.
Pang does not hold any ordinary shares and warrants in the Company.
Ang Chian Yen (“Ang”) joined our Group in October 2012.
Ang began her career with the Group as an Optometrist in OESC (TTDI branch), where she was primarily responsible for performing vision tests on customers using optometric equipment and diagnostic machines.
Ang was transferred to the operations department as an Operations Executive cum Optometrist and was subsequently promoted to the position of assistant operation manager. She was then promoted to the position of operations manager, where she has been responsible for ensuring that all our branches, doctors and nurses hold and maintain the requisite licenses and certificates for the purpose of complying with the MOH’s requirements as well as adhering to ISO standards with regards to clinical matters. In addition, she is also responsible for assisting our Chief Operating Officer in managing the overall operations of our Group.
Ang has promoted to Chief Operating Officer, Operations in FY2023 and now she is tasked in the establishment of strong governance, achievement of renowned healthcare quality accreditations and implementation of successful business strategies and process improvement plans in accordance with the goals and directions of our Group.
Ang holds 48,400 ordinary shares and 10,100 warrants directly in the Company.